Modulators of KEAP-1 Activity as Potential Therapies for the Treatment of Neurodegenerative Disorders

ACS Med Chem Lett. 2019 Aug 8;10(9):1245-1246. doi: 10.1021/acsmedchemlett.9b00328. eCollection 2019 Sep 12.

Author

Benjamin E Blass¹

Affiliation

¹ Temple University School of Pharmacy, Moulder Center for Drug Discovery Research, Philadelphia, Pennsylvania 19140, United States.

No abstract available

Publication types

Editorial